www.fdanews.com/articles/156686-biocad-said-to-seek-buyer-in-sale-that-may-top-1-billion

Biocad Said to Seek Buyer in Sale That May Top $1 Billion

June 27, 2013

Pfizer and Amgen are two bidders still in the race to buy Biocad, a Russian pharmaceutical company that attempts to produce biosimilars of cancer drugs.
Bloomberg